@article{JTD16588,
author = {Zhaofei Pang and Yufan Yang and Nan Ding and Cuicui Huang and Tiehong Zhang and Yang Ni and Jiajun Du and Qi Liu},
title = {Optimal managements of stage IIIA (N2) non-small cell lung cancer patients: a population-based survival analysis},
journal = {Journal of Thoracic Disease},
volume = {9},
number = {10},
year = {2017},
keywords = {},
abstract = {Background: This study aimed to investigate the optimal management of stage IIIA (cN2) non-small cell lung cancer (NSCLC) patients and determine potential predictive factors.
Methods: We extracted patients diagnosed as NSCLC stage IIIA (cN2) between 2004 and 2011 from Surveillance, Epidemiology, and End Results (SEER) database. Overall survival (OS) and lung cancer-speci c survival (LCSS) were compared among patients given different clinical managements by Kaplan-Meier method. Other variables such as age, sex and tumor size were analyzed to explore the factors associated with outcomes.
Results: A total of 98,700 IIIA-cN2 NSCLC patients were identified from SEER database. Survival of patients treated with surgery was better than that of patients treated by radiotherapy alone (P},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/16588}
}